BACKGROUND AND PURPOSE: Small vessel cerebrovascular disease is an important cause of vascular cognitive impairment. It is usually sporadic but also occurs secondary to the genetic disorder cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Recurrent lacunar stroke is a characteristic feature, although symptomatic events are relatively rare, making large numbers necessary for evaluation of potential therapies. Diffusion-weighted imaging is sensitive to acute ischemic lesions and differentiates them from chronic infarcts. Detection of asymptomatic lacunar infarcts with diffusion-weighted imaging is a potential surrogate marker for treatment trials. In this study, the frequency of asymptomatic new lesions in ischemic leukoaraiosis and CADASIL was determined as a step toward assessing the potential of this technique as a surrogate marker of disease activity. METHODS: Fifty patients with sporadic small vessel disease and 19 patients with CADASIL underwent diffusion-weighted imaging. All had been asymptomatic for 3 months before imaging. Diffusion-weighted images were screened by two raters for new lesions; lesions were confirmed as recent by a visible reduction of diffusivity on the corresponding apparent diffusion coefficient maps. RESULTS: Recent ischemic lesions were identified in four patients with sporadic small vessel disease (8.0%) and two patients with CADASIL (10.5%). CONCLUSION: Asymptomatic new lesions are found in cases of sporadic small vessel disease and CADASIL. The frequency of new lesions suggests that this approach has a potential role as a surrogate marker in therapeutic trials that warrants further investigation.
BACKGROUND AND PURPOSE: Small vessel cerebrovascular disease is an important cause of vascular cognitive impairment. It is usually sporadic but also occurs secondary to the genetic disorder cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Recurrent lacunar stroke is a characteristic feature, although symptomatic events are relatively rare, making large numbers necessary for evaluation of potential therapies. Diffusion-weighted imaging is sensitive to acute ischemic lesions and differentiates them from chronic infarcts. Detection of asymptomatic lacunar infarcts with diffusion-weighted imaging is a potential surrogate marker for treatment trials. In this study, the frequency of asymptomatic new lesions in ischemic leukoaraiosis and CADASIL was determined as a step toward assessing the potential of this technique as a surrogate marker of disease activity. METHODS: Fifty patients with sporadic small vessel disease and 19 patients with CADASIL underwent diffusion-weighted imaging. All had been asymptomatic for 3 months before imaging. Diffusion-weighted images were screened by two raters for new lesions; lesions were confirmed as recent by a visible reduction of diffusivity on the corresponding apparent diffusion coefficient maps. RESULTS: Recent ischemic lesions were identified in four patients with sporadic small vessel disease (8.0%) and two patients with CADASIL (10.5%). CONCLUSION: Asymptomatic new lesions are found in cases of sporadic small vessel disease and CADASIL. The frequency of new lesions suggests that this approach has a potential role as a surrogate marker in therapeutic trials that warrants further investigation.
Authors: P D Molyneux; M Filippi; F Barkhof; C Gasperini; T A Yousry; L Truyen; H M Lai; M A Rocca; I F Moseley; D H Miller Journal: Ann Neurol Date: 1998-03 Impact factor: 10.422
Authors: D H Miller; P S Albert; F Barkhof; G Francis; J A Frank; S Hodgkinson; F D Lublin; D W Paty; S C Reingold; J Simon Journal: Ann Neurol Date: 1996-01 Impact factor: 10.422
Authors: G C Román; T K Tatemichi; T Erkinjuntti; J L Cummings; J C Masdeu; J H Garcia; L Amaducci; J M Orgogozo; A Brun; A Hofman Journal: Neurology Date: 1993-02 Impact factor: 9.910
Authors: Adam de Havenon; Chelsea Meyer; J Scott McNally; Matthew Alexander; Lee Chung Journal: Curr Atheroscler Rep Date: 2019-07-27 Impact factor: 5.113
Authors: Pauline Maillard; Evan Fletcher; Samuel N Lockhart; Alexandra E Roach; Bruce Reed; Dan Mungas; Charles DeCarli; Owen T Carmichael Journal: Stroke Date: 2014-04-29 Impact factor: 7.914
Authors: T J Huynh; B Murphy; J A Pettersen; H Tu; D J Sahlas; L Zhang; S P Symons; S Black; T-Y Lee; R I Aviv Journal: AJNR Am J Neuroradiol Date: 2008-09-03 Impact factor: 3.825
Authors: Mike O'Sullivan; Elmar Ngo; Anand Viswanathan; Eric Jouvent; Andreas Gschwendtner; Philipp G Saemann; Marco Duering; Chahin Pachai; Marie-Germaine Bousser; Hugues Chabriat; Martin Dichgans Journal: Neurobiol Aging Date: 2007-10-25 Impact factor: 4.673
Authors: Johanna Helenius; E Murat Arsava; Joshua N Goldstein; Dean M Cestari; Ferdinando S Buonanno; Bruce R Rosen; Hakan Ay Journal: Ann Neurol Date: 2012-08 Impact factor: 10.422
Authors: Annemieke Ter Telgte; Kim Wiegertjes; Anil M Tuladhar; Marlies P Noz; José P Marques; Benno Gesierich; Mathias Huebner; Henk-Jan Mm Mutsaerts; Suzette E Elias-Smale; Marie-José Beelen; Stefan Ropele; Roy Pc Kessels; Niels P Riksen; Catharina Jm Klijn; David G Norris; Marco Duering; Frank-Erik de Leeuw Journal: Eur Stroke J Date: 2018-05-09